Discontinuation report RAPAFLO

Last updated on 2021-11-17 History
Report ID 149531
Drug Identification Number 02361671
Brand name RAPAFLO
Common or Proper name Silodosin Capsules
Company Name ALLERGAN INC
Market Status MARKETED
Active Ingredient(s) SILODOSIN
Strength(s) 8MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size HDPE Bottle 90s
ATC code G04CA
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for discontinuation Business reasons
Anticipated discontinuation date 2021-11-17
Actual discontinuation date
Remaining supply date 2022-02-01
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2021-11-17 French Compare
v1 2021-11-17 English Compare